Reuters: Vytorin fails to meet main goal of heart study

[chris]

Vytorin fails to meet main goal of heart study
      

NEW YORK (Reuters) - The cholesterol fighter Vytorin sold by Merck & Co Inc and Schering-Plough Corp failed to meet the main goal of improving outcomes better than a placebo in a closely-watched heart study, according to data presented on Monday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login